the challenges with monitoring patients with lymphoma for cardiotoxicity
Published 2 months ago • 53 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
1:40
challenges in monitoring for cardiotoxicity when treating patients with cll
-
1:54
navigating regulatory challenges in developing and approving therapies for rare lymphomas
-
1:30
managing the challenges associated with continuous bcma-directed therapy in multiple myeloma
-
1:22
managing adverse events associated with btkis when treating patients with mcl
-
2:45
swift-seq: single-cell rna sequencing of ctcs for patients with multiple myeloma and precursors
-
1:13
the challenges of treating patients with mpns who possess a tp53 mutation
-
1:38
predicting response to car-t therapy in lymphoma: challenges and strategies
-
4:25
the challenges with accurately diagnosing and risk-stratifying patients with mds
-
1:00:07
prospects for restoring vision in patients with glaucoma: the promise of optic nerve regeneration
-
9:00
navigating through frcpath part 1 exam
-
10:15
discovery eye foundation helps bring vision-saving retinitis pigmentosa treatment to patients.
-
1:07
characterizing distinct mechanisms of heart failure in patients with sickle cell disease
-
1:35
challenges with diagnosing mds and future outlooks
-
1:27
challenges in understanding the genomic landscape of hodgkin lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:17
integrating car-t in community-based practices across b-cell lymphomas: key challenges
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
2:17
key challenges in treating patients with t(11;14) multiple myeloma with bcl2 inhibitors
-
1:02
the challenge of treating bpdcn in a resource-limited setting
-
1:38
an overview of the practical challenges in approaching r/r amyloidosis
-
0:42
challenges with designing clinical trials for smoldering myeloma
-
2:07
challenges associated with the management of extramedullary myeloma & ongoing research